Notable values from Gritstone Oncology, Inc. (NASDAQ: GRTS) financials

On Monday, Gritstone Oncology, Inc. (NASDAQ: GRTS) shares price traded between $9.83 and $10.24 during the last trading session above with 0.79%at $10.20. The shares recorded trading volume 63,882 shares as compared to its average volume of 264.47K shares. The company has 36.39M shares outstanding and market value of 371.18M. Over the one year trading period, the stock has a peak price of $32.90 and its down is recorded at $8.75. The short ratio in the stock is 9.02 and the short float is around of 7.03%.

Gritstone Oncology, Inc. (NASDAQ: GRTS), recently stated recent business highlights and financial results for the first quarter ended March 31, 2019.

For the three months ended March 31, 2019, Gritstone stated a net loss of $18.0M, contrast to a net loss of $13.4M for the three months ended March 31, 2018.

Alliance revenue was $1.3M for the three months ended March 31, 2019, with no alliance revenue recognized for the three months ended March 31, 2018.

Total research and development expenses were $15.9M for the three months ended March 31, 2019, contrast to $11.4M for the three months ended March 31, 2018.

General and administrative expenses were $4.4M for the three months ended March 31, 2019, contrast to $2.0M for the three months ended March 31, 2018.

Cash, cash equivalents, and marketable securities were $132.2M as of March 31, 2019, contrast to $153.1M as of December 31, 2018. The first quarter ending cash position does not include the $74.8M in gross proceeds from the public stock offering that was completed in the second quarter.

Leave a Reply

Your email address will not be published. Required fields are marked *